Recent Progress of Small Interfering RNA Delivery on the Market and Clinical Stage
Molecular Pharmaceutics · 2024
DOI: 10.1021/acs.molpharmaceut.3c01158 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Fan Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Binzhou Medical University, Shandong 264003, China. Hauptthemen laut MEDLINE: RNA, Small Interfering. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 148 Literaturangaben.
Abstract (Originalsprache)
Small interfering RNAs (siRNAs) are promising therapeutic strategies, and five siRNA drugs have been approved by the Food and Drug Administration (FDA) and the European Commission (EC). This marks a significant milestone in the development of siRNA for clinical applications. The approved siRNA agents can effectively deliver siRNAs to the liver and treat liver-related diseases. Currently, researchers have developed diverse delivery platforms for transporting siRNAs to different tissues such as the brain, lung, muscle, and others, and a large number of siRNA drugs are undergoing clinical trials. Here, these delivery technologies and the latest advancements in clinical applications are summarized, and this Review provides a concise overview of the strategies employed for siRNA delivery to both hepatic and extrahepatic tissues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Binzhou Medical University, Shandong 264003, China.
- Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Shandong 264000, China.
- Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong 264117, China.
- Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
ORCID-Profile: Haiqiang Cao
Zitieren
APA
Guo, F., Li, Y., Yu, W., Fu, Y., Zhang, J., & Cao, H. (2024). Recent Progress of Small Interfering RNA Delivery on the Market and Clinical Stage. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.3c01158
Vancouver
Guo F, Li Y, Yu W, Fu Y, Zhang J, Cao H. Recent Progress of Small Interfering RNA Delivery on the Market and Clinical Stage. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.3c01158
BibTeX
@article{Guo2024,
author = {Guo, Fan and Li, Yan and Yu, Wenjun and Fu, Yuanlei and Zhang, Jing and Cao, Haiqiang},
title = {Recent Progress of Small Interfering RNA Delivery on the Market and Clinical Stage},
journal = {Molecular Pharmaceutics},
year = {2024},
doi = {10.1021/acs.molpharmaceut.3c01158}
}
EUVIMED